Every PMCPA ruling since 2005 — searchable and filterable by company, clause, and ABPI Code version.
Case Library Membership
Search free — but unlock advanced filters to find every case involving a specific company or clause.
Already a member? Sign in →
Case Library Membership
inc. VAT
inc. VAT · cancel any time
Secure payment via Stripe
Need access for your team?
Company licences available for compliance teams, medical affairs, and training programmes.
Get a team quote →1,930 cases found
Complaint alleged Otsuka’s Abilify Maintena tracking market research was promotional and used patient record forms like a clinical study, plus weak approvals.…
A UK senior employee ‘liked’ a global corporate LinkedIn post linking to product milestone news. The Panel said this proactively disseminated promotional…
A pharmacy training webinar hosted on a member site/YouTube became promotional when Valneva’s speaker mentioned products and “no competitors”, triggering missing AE…
Anonymous complaint alleged a Phase 2/3 sarcoma trial flyer in conference bags was pre-licence promotion and inappropriately distributed. Panel found the content…
Ex-employee alleged Otsuka withheld relevant facts and used unsigned witness statements in a 2015 PMCPA case response. Panel found breaches of Clauses…
A UAE-based leader posted about FDA/EMA approvals; a UK employee ‘liked’ it, which the Panel said proactively disseminated promotional POM content to…
A Novartis HCP website link to Tasigna “Great Britain Prescribing Information” mistakenly displayed Northern Ireland marketing authorisation numbers. The Panel ruled a…
A senior UK-based GSK medical employee ‘loved’ an external LinkedIn post about rectal cancer immunotherapy. Panel said this likely disseminated off-label promotion…
A UK physician alleged a shingles TV ad and linked disease-awareness site indirectly promoted GSK’s Shingrix. PMCPA Panel found the content balanced…
GSK’s Trelegy site and ERS leavepiece used broad superiority messaging and visuals that implied statistical significance where it wasn’t shown, plus an…
A Germany-based employee posted “Hope for patients with Lennox-Gastaut Syndrome!” linking to a US press release about Fintepla. A senior UK employee…
A Trelegy promotional video summarising an ERS 2022 symposium overstated statistical significance in NMA comparisons on COPD exacerbations, leading to breaches for…
Nine MSD UK employees ‘liked’ an NHS England LinkedIn post about pembrolizumab, including “cancer-free” patient story. PMCPA ruled breaches of Clauses 5.1,…
GSK’s HCP webpage/video used an NMA to headline “greater exacerbation reduction” vs other COPD SITTs. PMCPA ruled the headline comparison misleading (Clauses…
At ERS 2022, GSK-sponsored symposium slides on a COPD network meta-analysis were ruled misleading/unsubstantiated (Clauses 6.1, 6.2, 5.1). Allegations about MSLs acting…
Our PMCPA rulings expert has knowledge of over 1,900 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.
